small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 79 results

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Practice Area

Patent Litigation

Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022)....Read more

Industry

Maritime & Admiralty

Experience 80 results

Experience

|

August 22, 2025

2025 EnCore Convertible Notes Offering

Winston & Strawn LLP represented enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) in its offering of $115M in aggregate principal amount of its 5.50% Convertible Senior Notes due 2030. The proceeds include the full exercise of the option by the initial purchasers to purchase an additional $15M aggregate principal amount of the Convertible Notes granted by enCore to the initial purchasers. The Convertible Notes were sold in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended....Read more

Experience

|

June 8, 2025

A Team Co-led by Winston & Strawn Negotiates a Landmark Antitrust Class Action Settlement with the NCAA and Its Power 5 Conferences

Secured, with co-counsel, final approval of an historic settlement of over US$2.75B in back-damages for current and former college-athletes and a new revenue-sharing model allowing schools to share future earnings with athletes. This decade-long effort across four different lawsuits redefines the economics of college sports, affirming athlete rights and fair compensation. Following a 9-0 Supreme Court victory in Alston v. NCAA, the team filed three antitrust class actions, resulting in a groundbreaking settlement that creates a revenue-sharing system projected to generate at least US$20B in new, previously prohibited payments and benefits to Division I college athletes over the next decade. The settlement was recognized in Am Law‘s Litigator of the Week column....Read more

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Winston & Strawn represented Revere Securities LLC acted as the lead placement agent in connection with PicoCELA, Inc. in the closing of its public offering of 6,100,000 American Depositary Shares ("ADSs") at a public placement price of $0.30 per ADS. PicoCELA, Inc. received an aggregate gross proceeds of $1.83 million before deducting placement agent commission and other offering expenses. Each ADS represents one common share of the Company....Read more
View All Experience

Insights & News 3,531 results

Seminar/CLE

|

January 20, 2026

2026 NYC SBIC Fund Conference

Winston & Strawn and RSM US LLP are co-hosting the annual NYC SBIC Fund Conference on Tuesday, January 20, 2026.General and limited partners, chief financial officers, and controllers of small business investment company (SBIC) funds are invited to a half-day seminar covering various topics related to SBIC fund operations, including:...Read more

Article

|

January 6, 2026

|

5 Min Read

Guardrails Before Greenlights: How Gen AI Will Actually Shape E-discovery in 2026

This article was originally published in LegalTech News. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only....Read more

Client Alert

|

December 31, 2025

|

4 Min Read

New York FAIR Business Practices Act Bolsters State’s Consumer Protection Framework

Not quite a year after the Consumer Financial Protection Bureau (CFPB) issued its January 2025 report urging states to strengthen state-level consumer protections, New York enacted the Fostering Affordability and Integrity through Reasonable (FAIR) Business Practices Act into law. The FAIR Act amends New York’s general business law to prohibit unfair and abusive business acts and practices beyond deceptive conduct.

View All Insights & News

Other Results 113 results

Law Glossary

What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?

There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation....Read more

Law Glossary

What Is the Approval Process for Generic Drugs?

Approval for generic drugs are governed by the Hatch-Waxman Act. The Hatch-Waxman Act provides the framework for an applicant to demonstrate that its proposed generic product is bioequivalent to the brand-name drug....Read more

Site Content

The Corporate Transparency Act
Task Force

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising